Can antipsychotic use protect from COVID-19?
- PMID: 34352504
- PMCID: PMC8321781
- DOI: 10.1016/j.schres.2021.07.035
Can antipsychotic use protect from COVID-19?
Keywords: Antipsychotics; COVID-19; Cytokines; Interleukin-6; SARS-CoV-2; Schizophrenia.
Conflict of interest statement
None.
Comment on
-
Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population.Schizophr Res. 2021 Mar;229:53-54. doi: 10.1016/j.schres.2021.02.002. Epub 2021 Feb 19. Schizophr Res. 2021. PMID: 33631466 Free PMC article. No abstract available.
References
-
- Canal-Rivero M., Catalán-Barragán R., Rubio-García A., Garrido-Torres N., Crespo-Facorro B., Ruiz-Veguilla M., IBIS Translational Psychiatry Group Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population. Schizophr. Res. 2021;229:53–54. doi: 10.1016/j.schres.2021.02.002. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous